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Thousands of chemicals have been profiled by high-throughput screening programs
such as ToxCast and Tox21; these chemicals are tested in part because most of them
have limited or no data on hazard, exposure, or toxicokinetics. Toxicokinetic models
aid in predicting tissue concentrations resulting from chemical exposure, and a “reverse
dosimetry” approach can be used to predict exposure doses sufficient to cause tissue con-
centrations that have been identified as bioactive by high-throughput screening. We have
created four toxicokinetic models within the R software package httk. These models are
designed to be parameterized using high-throughput in vitro data (plasma protein bind-
ing and hepatic clearance), as well as structure-derived physicochemical properties and
species-specific physiological data. The package contains tools for Monte Carlo sampling
and reverse dosimetry along with functions for the analysis of concentration vs. time sim-
ulations. The package can currently use human in vitro data to make predictions for 553
chemicals in humans, rats, mice, dogs, and rabbits, including 94 pharmaceuticals and 415
ToxCast chemicals. For 67 of these chemicals, the package includes rat-specific in vitro
data. This package is structured to be augmented with additional chemical data as they
become available. Package httk enables the inclusion of toxicokinetics in the statistical
analysis of chemicals undergoing high-throughput screening.
Keywords: high-throughput, ToxCast, httk, toxicokinetics, pharmacokinetics.
1. Introduction
Humans are exposed to thousands of chemicals from the environment and consumer products,
most of which have not been tested for toxicity (Park et al. 2012; Wambaugh et al. 2013b;
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Egeghy et al. 2011; Judson et al. 2008). In order to screen for potential bioactivity, in vitro
data have been generated in the Tox21 (Bucher 2008) and ToxCast (Judson et al. 2010)
programs using high-throughput screening systems. Over 8500 chemicals have been tested in
at least 50 assays (Tox21), and a subset of around 1800 have had nearly 1200 assay endpoints
measured (ToxCast). Recently, high-throughput exposure modeling has provided estimates of
daily human exposure for thousands of environmental contaminants (Wambaugh et al. 2014).
However, linking these hazard and exposure predictions to estimate risk requires development
and use of high-throughput toxicokinetics. The terms “pharmacokinetic”, “toxicokinetic”,
and “biokinetic” models have been used somewhat interchangeably in the scientific literature.
However, since this package is intended to provide dose context to high-throughput toxicity
screening projects, we have selected the term “toxicokinetic” even though we include several
compounds with known therapeutic benefits and many others that may not cause adversity
for the highest plausible dose.
Toxicokinetics is a field of study for determining the absorption, distribution, metabolism,
and excretion of substances in the body (O’Flaherty 1981). The necessary data for toxicoki-
netics are commonly collected in rats and other animals, but the collection of these data for
thousands of chemicals is costly in time, money, and animals (Rovida and Hartung 2009).
Creating computational predictive models parameterized with more easily obtained in vitro
data may help address these problems. Inputting estimated exposures into toxicokinetic mod-
els yields information about the steady state and time course concentrations in various parts
of the body. These concentrations can then be compared to concentrations that cause bio-
logical activity in in vitro assays. The models can also be used in a reverse manner, known
as reverse toxicokinetics, by predicting the dose needed to produce a specific concentration
of interest, such as the in vitro AC50 or other levels of biological activity as done in Wet-
more et al. (2012) and Wetmore (2015). Thus chemicals can be ranked based on the ratio
of the predicted exposure dose to the back-calculated bioactive dose (Thomas et al. 2013),
which, due to the linearity of these models, is equal to the ratio of the predicted steady state
concentration to the in vitro bioactive concentration.
Many basic toxicokinetic models (Wetmore et al. 2012; Wetmore 2015; Pelekis et al. 1997)
only predict steady state plasma concentrations (Css), assuming a dose rate that is both
continuous and constant (e.g., infusion dose). With a more dynamic model, such as a phys-
iologically based toxicokinetic (pbtk) model, we can simulate discrete doses to reach steady
state, which we observe to oscillate around the infusion dose prediction. Our pbtk models
include multiple compartments with partition coefficients. These models are expressed as a
set of mass balance differential equations describing the rate of change of the amount of a
substance in each compartment. Chemical-specific physicochemical data and species-specific
in vitro and physiological data are used in calculating the partition coefficients, clearance,
tissue volumes, and blood flows. These in vitro data consist of the intrinsic hepatic clearance,
Clint, and the plasma protein binding, fub. httk provides tools for Monte Carlo sampling and
reverse dosimetry (Tan et al. 2006) along with functions that solve for concentration vs. time
curves, steady state concentrations, the number of days to steady state, and other toxicoki-
netic summary statistics for chemicals as shown in Tables 4 and 5 with the corresponding
abbreviations in Table 1. With this R package we provide data, models, and examples to
allow the inclusion of toxicokinetics in statistical analysis of chemical exposure and toxicity
for 553 chemicals. The package is structured to be modular and expandable to allow new
modeling approaches and chemical data to be added as they become available.
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Variable Name
1compartment One compartment model (O’Flaherty 1981), shown in Figure 1.
3compartment Three compartment model (Jamei et al. 2009), shown in Figure 1.
3compartmentss Three compartment steady state model (Wetmore et al. 2012; Wetmore
2015).
BW Body weight.
Css Average plasma concentration of a chemical at steady state.
Clint In vitro intrinsic hepatic clearance.
Clmetabolism Whole liver hepatic clearance, scaled from Clint .
Clwell−stirred Hepatic clearance modeled with well-stirred approximation using
Clmetabolism .




kgutabs Gut absorption rate, default of 1 h−1.
logP Logarithm (base 10) of octanol to water partition coefficient.
pbtk Physiologically based toxicokinetic model, shown in Figure 1.
PM Poor metabolizers.
Qcardiac Cardiac output, blood flow through the heart and lungs.
Qgfr Glomerular filtration rate.
Qrest The difference between Qcardiac and the flow to the liver, kidney, and gut.
Qtissue Blood flow to a tissue.
QSAR Quantitative structure-activity relationship.
Rblood2plasma Ratio of the blood concentration of a chemical to the plasma concentra-
tion.
SBML Systems biology markup language.
SMILES Simplified molecular-input line-entry system.
Vdist Volume of distribution, the weighted sum of all partition coefficients.
Table 1: List of abbreviations.
2. Methods
Version 1.7 of httk (Wambaugh et al. 2017) is used in this manuscript. The package is
available from the Comprehensive R Archive Network (CRAN) at https://CRAN.R-project.
org/package=httk.
2.1. Models included
The four models in httk include: “pbtk”, “3compartment”, “3compartmentss”, and “1com-
partment”; the predictions and parameters of these models are compared in Table 2. All
models currently use only oral and intravenous (i.v.) dosing. The models pbtk and 3com-
partment, shown in Figure 1, use tissue to unbound plasma partition coefficients calculated
with a modified version of Schmitt’s model (Schmitt 2008b) (using octanol-water partition-
ing, membrane affinity, acid/base dissociation constants, tissue compositions, and adjusted
fub) to simulate chemical concentrations over time for multiple tissue compartments. The



















































































pbtk Yes Yes Yes Yes Yes Yes No No Yes Yes
1compartment No No No No Yes No Yes Yes Yes Yes
3compartment Yes Yes Yes Yes Yes Yes No No Yes Yes
3compartmentss Yes No Yes No Yes No No No No Yes
Table 2: Model parameter and prediction comparison. *Partition coefficients are needed in
calculating Vdist . Clearances and fub are needed in calculating kelim .
model pbtk contains separate tissue compartments for the gut, liver, lungs, arteries, veins,
and kidneys while the model 3compartment only contains compartments for the liver and gut
and is essentially a condensed form of the model pbtk. The tissues contained in tissue.data
that are unused in each of these models are aggregated into a single compartment termed
“rest”, whose partition coefficient is calculated by averaging the remaining partition coeffi-
cients, weighted by their species-specific tissue volumes. Absorption from the gut lumen into
gut tissue is modeled as a first order process with an arbitrary “fast” absorption rate of 1
h−1. The fraction of the dose absorbed into the system through the gut wall is set to 1 when
measured data are unavailable. The gut blood flows directly into the liver, where the hepatic
clearance, Clmetabolism , is calculated with a unit conversion of Clint using the density of hep-
atocytes in the liver (1.1 × 108 hepatocytes per gram of liver from Ito and Houston 2004 and
a liver density of 1.05 g/mL from Snyder et al. 1975). Both models also feature renal elim-
ination by passive glomerular filtration through the kidneys. We assume perfusion-limited
tissue (i.e., tissue, red blood cells, and plasma come to equilibrium rapidly with respect to
the flow of blood), and a constant Rblood2plasma is used throughout the body, predicted using
hematocrit and the predicted partitioning between red blood cells and plasma when in vivo
values are unavailable.
The models 3compartmentss and 1compartment both contain only plasma without separate
compartments for blood and tissue (and thus no individual partition coefficients). The model
3compartmentss, “ss” standing for steady state, is a single equation for the Css of the rest-
of-body compartment in the model 3compartment resulting from i.v. dosing. This is the
same equation used for determining Css in previous work (Rotroff et al. 2010; Wetmore et al.
2012; Wetmore 2015; Wilkinson and Shand 1975) but with a modification adjusting for the
misuse of hepatic blood flow in determining plasma clearance (Yang et al. 2007). The model
1compartment features an absorption compartment and a total clearance equal to the sum
of the metabolism of the parent compound in the liver, modeled with the adjusted “well-
stirred” approximation (Wilkinson and Shand 1975; Houston and Carlile 1997), and the renal
clearance by passive glomerular filtration. The elimination rate, ke, is equal to the total
clearance divided by the volume of distribution, Vdist . Vdist is used as the volume of the
compartment and is calculated by summing the plasma volume and the products of each
tissue to unbound plasma partition coefficient, its corresponding volume, and fub (Schmitt
























































Figure 1: Models (A) 1compartment, (B) 3compartment, and (C) pbtk. In order to preserve
mass-balance, Qrest is defined as the difference between Qcardiac and the flow to the liver,
kidney, and gut. Variable names are defined in Table 1.
2008b). Css resulting from infusion dosing for the model 1compartment is equivalent to
3compartmentss.
Among the four models in the package, the simplest model, 3compartmentss, is applicable to
the largest number of chemicals, specifically those which are missing information needed to
parameterize the other models. It is the only model that does not use partition coefficients
and thus does not require logP, and when fub is below the limit of detection, the model can be
used with Monte Carlo to simulate Css distributions. Thus, fub below the limit of detection
(set to zero in chem.physical_and_invitro.data and 0.005 in default parameter lists) and
Clint are the minimum data requirements for running a model. The model 1compartment is
included to compare our predictions with in vivo experiments which are often characterized
by one compartment model parameters (Vdist and kelim). We note that fully understand-
ing the kinetics of a given chemical might require additional data on features currently not
accessible with high-throughput in vitro approaches, such as bioavailability, transporters,
protein-binding kinetics, and extra-hepatic or strongly saturable metabolism (Rotroff et al.
2010).
2.2. Model equations
The differential equations below describe changes in the concentrations or amounts of a sub-
stance within the model compartments. Although the models are written as changes in
tissue concentrations, except for the gut lumen, the equations actually express changes in
the amount of substance in the blood of each tissue divided by the tissue volume with the
blood and tissue concentrations related through the out-flowing concentration in blood. A
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blood flow, Q (L/day), multiplied by a concentration, C (mol/L), is equal to the amount
of the substance entering or leaving a compartment through the blood, QC (mol/day). We
define partition coefficients as the ratio of the concentration in a tissue to the unbound con-
centration in plasma of that tissue; Ktissue2pu = Ctissue/(fubCplasma). Thus dividing Ctissue by
Ktissue2pu and fub and then multiplying by Rblood2plasma yields the blood concentration of the
compartment at equilibrium, CtissueRblood2plasma/(fubKtissue2pu). Assuming perfusion-limited
tissue, we substitute this term for the out-flowing blood concentrations (Campbell Jr et al.
2012) and assume negligible blood volume fractions in all tissues to justify dividing by the
tissue volume without a blood volume fraction and partition coefficient dependency. The
flow to the rest-of-body, Qrest , is calculated by subtracting the sum of all the other tissue
flows (i.e., gut, liver, and kidney) from the total cardiac output. The glomerular filtration
rate, Qgfr , and the hepatic clearance, Clmetabolism , (both in L/day) are both multiplied by
the unbound plasma concentrations, Ctissue/Ktissue2pu , in the kidney and liver to express the
amount of the substance leaving the system. Note that although the units of the clearances,
flows, and absorption rate are in days, being consistent with the model outputs, they are
initially entered in units of hours. The model 3compartmentss assumes a constant dose rate,
kdose (mg/kg BW/day), and the other models use discrete changes in the amount in the gut
lumen or venous concentration, depending on which type of dose is specified. The function
that is part of the gut lumen equation, g(t) describes the oral dosing schedule. MCSim (Bois
and Maszle 1997) was used for converting the model equations into C code, which is used

































































































































































(Qliver +Qgut) + fubClmetabolism/Rblood2plasma
)
2.3. In vitro chemical data
In vitro experiments provide empirical data for two model parameters. The first, Clint ,
the intrinsic hepatic clearance of the parent compound by primary hepatocytes (substrate
depletion approach), was measured in a well on a multi-compound plate (Shibata et al. 2002).
This was determined by dividing the in vitro clearance of the unbound parent chemical by
the fraction of chemical unbound in the hepatocyte intrinsic clearance assay provided in the
parameter lists, which was estimated using a distribution coefficient calculated from pKa
and the method of Kilford et al. (2008). The second in vitro measurement is fub, assessed
using rapid equilibrium dialysis (RED) in which two wells are separated by a membrane that
is permeable by smaller molecules but prevents the plasma protein added to one well from
migrating to the other well (the relative chemical concentration in the two linked wells gives
the free fraction of chemical; Waters et al. 2008). However, the default value used in the
models is adjusted for absent binding in vitro (Poulin and Haddad 2012).
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Data table Description
chem.invivo.PK.data This data set includes time and dose specific measurements of
chemical concentrations in tissues taken from animals administered
control doses of the chemicals either orally or intravenously. These
plasma concentration-time data are from rat experiments reported
in public sources. Toxicokinetic data were retrieved from those
studies by the Netherlands Organisation for Applied Scientific Re-
search (TNO) using curve stripping (TechDig v2). These data are
provided for statistical analysis as in Wambaugh et al. (2015).
chem.invivo.PK.-
summary.data
This data set summarizes the time course data in the
chem.invivo.PK.data table. Maximum concentration (Cmax),
time integrated plasma concentration for the duration of treat-
ment (AUC.treatment) and extrapolated to zero concentration
(AUC.infinity) as well as half-life are calculated. Summary val-
ues are given for each study and dosage.
chem.physical_and_-
invitro.data
This data set contains the necessary information to make basic,
high-throughput toxicokinetic predictions for compounds, includ-
ing fub, Clint , molecular weight, logP, logMA (membrane affinity),
and pKa.
tissue.data This data set contains values from Ruark et al. (2014) describing
the composition of specific tissues and from Snyder et al. (1975)
and Birnbaum et al. (1994) describing volumes of and blood flows
to those tissues, allowing parameterization of toxicokinetic models
for human, mouse, rat, dog, or rabbit.
physiology.data This data set contains additional physiological values necessary to
parameterize a toxicokinetic model for human, mouse, rat, dog, or
rabbit.
Wetmore.data This data set gives the chemical-specific predictions for serum con-
centration at steady state resulting from infusion exposure at a
constant rate, as published in a series of papers from Barbara Wet-
more’s group (Wetmore et al. 2012, 2013; Wetmore 2015) at the
Hamner Institutes for Life Sciences. Predictions include the me-
dian and 90% interval in µM and mg/L. Calculations were made
using the 1 and 10 µM in vitro measured clearances.
Table 3: List of data tables in the package. In Ring et al. (2017), a series of tables for gen-
erating populations based on variation in human physiology were added. They are described
in that manuscript and vignettes.
For non-pharmaceutical chemicals, in vitro experimental data were obtained primarily from
Wetmore et al. (2012), Wetmore (2015), and Tonnelier et al. (2012) for humans and Wet-
more et al. (2013) for rats. For pharmaceutical compounds these values are compiled from
Obach (1999), Jones et al. (2002), Naritomi et al. (2003), Ito and Houston (2004), Ri-
ley et al. (2005), Schmitt (2008a), and Obach et al. (2008). These data are contained in
chem.physical_and_invitro.data.
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2.4. Physicochemical properties
Physicochemical properties were collated from various sources: Molecular weight and struc-
ture are determined from the DSStox database (http://www.epa.gov/ncct/dsstox), and
octanol to water partitioning is predicted for most compounds with EPA’s estimation pro-
gram interface (EPI) suite (http://www.epa.gov/tsca-screening-tools/epi-suitetm-
estimation-program-interface). EPI suite quantitative structure activity relationships
(QSARs) were used to estimate octanol to water partitioning (logP) if simplified molecular
input line entry system (SMILES) descriptions of chemical structure were available and the
QSARs did not fail for that structure. In addition to QSAR model estimates, EPI suite
contains a database of experimentally obtained octanol to water partition coefficients that
were used in place of estimated values when available. Where available, ionization asso-
ciation/dissociation equilibrium constants (pKa) were curated from the literature; otherwise
predictions were made from structure using the SPARC (which performs automated reasoning
in chemistry) model (Hilal et al. 1995). Membrane affinities (i.e., lipid-bilayer to water con-
centration ratios) are predicted using a regression from Yun et al. (2014), based on octanol
to water partitioning and membrane affinity values from Schmitt (2008b), when measured
values are unavailable. These data are contained in chem.physical_and_invitro.data.
2.5. Physiological and tissue data
The tissue data needed for calculating partition coefficients in human and rat, taken from
Ruark et al. (2014), include: cellular and water fractions of total volume, lipid and protein
fractions of cellular volume, lipid fractions of the total lipid volume, the pH of each tissue,
and the fractional volume of protein in plasma. A default plasma pH of 7.4 is taken from
Schmitt (2008b) in calculating ionization. The partition coefficient for the mass and volume
of the body unaccounted for by the tissues included in Schmitt (2008b) is calculated with the
averages of the fractional volumes and pH of these tissues, excluding red blood cells. Tissue
volumes and liver density are taken from Snyder et al. (1975). Blood flows are from Birnbaum
et al. (1994). Tissue volumes are scaled linearly to body weight while the flows, including
glomerular filtration, are scaled by body weight to the 3/4 power (Campbell Jr et al. 2012).
The available data for the fraction of a dose absorbed into the gut lumen are taken from
Naritomi et al. (2003). The remaining data are taken from Davies and Morris (1993). These
data are included in the physiology.data and tissue.data tables that are accessible in the
package.
2.6. Determination of steady state
Although the discrete dosing in our models produces an oscillating steady state, we use the
steady state resulting from equivalent oral infusion dosing at a constant rate, calculated by
analytically solving the differential equations at steady state, to determine when steady state
is reached. The day a chemical reaches steady state is found by determining when the average
concentration of the numerically solved solution for a given day falls within a specified percent
of the analytic solution from oral infusion dosing, calc_css defaulting to 1%.
2.7. Monte Carlo sampler
The package contains a Monte Carlo sampler, HTTK-Pop (Ring et al. 2017), used in
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calc_mc_css for probabilistically simulating human biological variability and measurement
uncertainty in parameters determining Css (Thomas et al. 1996). HTTK-Pop uses physiologies
based on distributions of demographic and anthropometric quantities from the most recent
U.S. Centers for Disease Control and Prevention National Health and Nutrition Examination
Survey (NHANES) data (Johnson et al. 2014). This allows incorporation of inter-individual
variability, including variability across relevant demographic subgroups which can be speci-
fied through the arguments gendernum, agelim_years/agelim_months, weight_category,
gfr_category, and reths, respectively specifying the relative numbers of genders, age ranges,
body weights, kidney function, and racial ethnicity for the simulated population. By default,
the total U.S. population is represented (Johnson et al. 2014). HTTK-Pop accounts for
the correlation structure in physiological parameters (Ring et al. 2017). Two methods for
sampling individuals are available: the default, direct resampling (method="dr") uses actual
individuals from the NHANES. If the number of individuals for a specific demographic group
is small, larger numbers of virtual individuals (method="vi") can be generated. Prior to
version 1.5, the package relied upon a Monte Carlo sampler that used uncorrelated normal
distributions that were truncated to ensure positive values. The distributions can be changed,
but default to a mean equal to the model parameter estimate and a coefficient of variation
of 0.3. For humans, setting httkpop to FALSE allows the original uncorrelated Monte Carlo
sampler to be used. HTTK-Pop is only used for humans, and so for all non-human species
the original sampler is still used.
Body weight, liver volume and blood flow, cellular density in the liver, andQgfr are all varied as
described above. HTTK-Pop varies Clmetabolism by varying three quantities. Hepatocellularity
(106 cells/g liver) and liver weight (kg) are varied based on NHANES biometrics (Ring et al.
2017). The chemical specific in vitro measured Clint is varied according to a Gaussian mixture
distribution to represent the population proportions of poor metabolizers (PMs) and non-PMs
of each substance. With probability 0.95, Clint was drawn from a non-PM distribution: a
normal distribution truncated below at zero, centered at the value measured in vitro, with a
coefficient of variation of 0.3. With probability 0.05, Clint was drawn from a PM distribution:
a truncated normal distribution centered on one-tenth of the in vitro value with coefficient
of variation 0.3. fub is drawn from a censored distribution with identical properties to the
other distributions, where values are sampled from a uniform distribution between 0% and the
limit of detection (default of 1% unbound) at a rate proportional to the number of samples
from the truncated normal distribution below the limit of detection. fub below the limit
of detection (set to zero in chem.physical_and_invitro.data) is set to a default value of
0.005 in the model parameters. For each chemical, a default of 1000 different combinations
of parameters are used to determine Css. These concentrations are determined with doses
of 1 mg/kg BW/day but, given the linear concentration response of the models, can be
extrapolated to other doses with calc_mc_css. Using calc_mc_oral_equiv, we can, in a
reverse manner, back-calculate the dose for a given concentration and quantile. The functions
get_wetmore_css and get_wetmore_oral_equiv perform the same operations on doses and
concentrations using the published Css results from Wetmore et al. (2012), Wetmore et al.
(2013), and Wetmore (2015), contained in the Wetmore.data table, which used the same in
vitro data as contained in the package. However, these data only contain the 5%, median,
and 95% quantiles for humans and the median for rats. These results were obtained with
the SimCYP population simulator (Jamei et al. 2009) in a manner identical to the default
simulation in calc_mc_css with two exceptions. The Wetmore data assumed fub = 0.005 for
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chemicals with fub below the limit of detection instead of sampling the value from a censored
distribution, and the Clmetabolism values were accepted as nonzero if the p value was less than
0.1 instead of 0.05 as used in our sampler.
3. Examples
The following examples are run with version 1.7 and may not generate the same outputs as
other versions. New versions of the package typically correspond to submission to or revision
of manuscripts for peer-reviewed scientific journals (Wambaugh et al. 2015; Wetmore 2015;
Ring et al. 2017). If using httk for regulatory purposes, a copy of the version used should be
archived. To check if the version installed is 1.7 or greater:
R> packageVersion("httk") >= "1.7"
3.1. Accessing and changing model parameters
httk allows the user to access and change the parameters used in each of the models. Each of
the models contains their own parameterize function that generates a list of the parameters
required by the model. For example, to get a list of parameters for the pbtk model of triclosan
in a rat:
R> parameters <- parameterize_pbtk(chem.name = "triclosan", species = "rat")
To see the effect a change in parameters has on the model, we can modify the desired entries in
the list and use the new parameter list as an input for the parameters argument of a function
that uses that model. For example, to change the fub in the previous parameters list to 0.1
from the default of 0.005 (noting the warning that fub is below the limit of detection) and
use it in a simulation of the pbtk model for a single dose of 1 mg/kg BW of triclosan in a rat:
R> parameters["Funbound.plasma"] <- 0.1
R> out <- solve_pbtk(parameters = parameters)
Individual parameters such as Rblood2plasma, total clearance, Vdist , metabolic clearance, and
kelim can also be calculated using the functions with the prefix calc followed by the parameter
name and the same arguments as the above parameterize function.
3.2. Making data frames and tables
In order to compare predictions or models, we can construct tables or data frames. Suppose
we want to look at how Css at 1 mg/kg BW/day compares for the model pbtk, the median
of the Monte Carlo simulation, and the Wetmore data. We can construct a data frame
(used with ggplot2, Wickham 2009, in the following examples) containing these data with
a for loop. The intersection of get_wetmore_cheminfo and get_cheminfo contains all the
CAS numbers that will work for all three functions. In the example below, setting model
to "pbtk" in get_cheminfo removes the chemicals from the list with fub below the limit of
detection. This is the same as setting exclude.fub.zero to TRUE. However, we could include
these chemicals by using the default model option of "3compartmentss", and fub would then
automatically be set to 0.005.
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Function Description
add_chemtable Adds chemical data for HTTK analysis.
available_rblood2plasmaRetrieves Rblood2plasma (measured preferred over predicted)).
calc_analytic_css Calculates Css and blood concentrations for the four models used
in the package from infusion dosing at a constant rate.
calc_css Calculates the maximum and average steady state concentra-
tions along with the day steady state is reached.
calc_elimination_rate Calculates kelim for a one compartment model due to the liver
and kidneys, dividing the total clearance by Vdist .
calc_hepatic_clearance Calculates the hepatic clearance for a well-stirred model or other
type if specified (Ito and Houston 2004).
calc_mc_css Calculates Css using Monte Carlo simulation, defaulting to
HTTK-Pop simulator (Ring et al. 2017).
calc_mc_oral_equiv Calculates an oral equivalent dose using Css from calc_mc_css.
calc_rblood2plasma Calculates the blood:plasma chemical concentration ratio.
calc_stats Calculates the area under the curve, mean, and peak values for
the blood or plasma concentration of either a specified chemical
or all chemicals for a given simulation.
calc_total_clearance Calculates the total clearance rate for a one compartment
model where clearance is equal to the sum of the well-stirred
metabolism by the liver and glomerular filtration in the kidneys.
calc_vdist Calculates the one compartment volume of distribution.
export_pbtk_jarnac Exports the model pbtk to Jarnac (Sauro and Fell 2000).
export_pbtk_sbml Exports the model pbtk to SBML (Hucka et al. 2003).
get_cheminfo Provides a list of CAS numbers along with compound names,
logP, pKa, molecular weight, Clint and its p value, and fub if
specified for chemicals with sufficient data for a given model.
get_httk_params Converts table generated by httkpop_generate to the corre-
sponding table of httk model parameters.
get_rblood2plasma Retrieves in vivo Rblood2plasma.
get_wetmore_cheminfo Provides the names and CAS numbers of chemicals with infor-
mation from Wetmore et al. (2012), Wetmore et al. (2013), and
Wetmore (2015).
get_wetmore_css Retrieves Css as a result of oral infusion dosing from Wetmore
et al. (2012), Wetmore et al. (2013), and Wetmore (2015).
get_wetmore_
oral_equiv
Calculates an oral equivalent dose using Css from Wetmore et al.
(2012), Wetmore et al. (2013), and Wetmore (2015).
httkpop_generate Generates a virtual population.
lump_tissues Lumps tissue flows, volumes, and input partition coefficients
based on specified grouping.
Table 4: List of functions in the package – Part I. Models are described in Table 2. Parameters
are defined in Table 1. Jarnac and SBML are external languages for systems biology models.
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Function Description
monte_carlo Runs a Monte Carlo simulation of a given model.
parameterize_1comp Parameterizes the model 1compartment.
parameterize_3comp Parameterizes the model 3compartment.




Parameterizes the model 3compartmentss, used in Wetmore
et al. (2012) and Wetmore (2015).
predict_partitioning_
schmitt
Predicts partition coefficients using Schmitt’s method (Schmitt
2008b).
solve_1comp Solves the model 1compartment.
solve_3comp Solves the model 3compartment.
solve_pbtk Solves the model pbtk.
Table 5: List of functions in the package – Part II. Models are described in Table 2. Param-
eters are defined in Table 1. Jarnac and SBML are external languages for systems biology
models.
R> table <- NULL
R> for (this.cas in intersect(get_cheminfo(model = "pbtk"),
+ get_wetmore_cheminfo())) {
+ this.row <- as.data.frame(this.cas)
+ this.row <- cbind(this.row, as.data.frame(calc_analytic_css(
+ chem.cas = this.cas, model = "pbtk", output.units = "mg/L")))
+ this.row <- cbind(this.row, as.data.frame(get_wetmore_css(
+ chem.cas = this.cas, which.quantile = 0.50)))
+ this.row <- cbind(this.row, as.data.frame(calc_mc_css(
+ chem.cas = this.cas, which.quantile = 0.50)))
+ table <- rbind(table, this.row)
+ }
R> colnames(table) <- c("CAS", "PBTK", "Wetmore", "MC")
3.3. Plotting
Concentration vs. time
The function solve_pbtk has the option of returning plots for the compartment concentra-
tions vs. time, but to see how Css resulting from discrete dosing deviates from the average
steady state concentration, we can make a plot with ggplot2 that includes a horizontal line
through the y axis at the predicted Css for oral infusion dosing (Figure 2). We calculate the
analytic Css and enter it into geom_hline as the y intercept and add all the other options to
our ‘ggplot’ object.
R> library("ggplot2")
R> out <- solve_pbtk(chem.name = "Bisphenol A", days = 50, doses.per.day = 3)
R> plot.data <- as.data.frame(out)
























Figure 2: Css at 3 doses per day, 1 mg/kg BW/day.
R> css <- calc_analytic_css(chem.name = "Bisphenol A")
R> c.vs.t <- ggplot(plot.data,aes(time, Cplasma)) + geom_line() +
+ geom_hline(yintercept = css) + ylab("Plasma Concentration (uM)") +
+ xlab("Day") + theme(axis.text = element_text(size = 16),
+ axis.title = element_text(size = 16),
+ plot.title = element_text(size = 17, hjust = 0.5)) +
+ ggtitle("Bisphenol A")
R> c.vs.t
This example plots the concentration vs. time of 1 mg/kg BW/day of Bisphenol A broken into
three doses per day. The same plots can be made for the other models by substituting one of
the other two solve functions, solve_3comp or solve_1comp, for solve_pbtk and setting the
model argument of calc_analytic_css to the corresponding model. These three functions
also have the option of simulating a single oral or i.v. dose and setting the initial values of
each compartment with units matching the specified output units (default is µM).
Days to steady state histogram
Creating histograms can allow us to visualize how a given value varies across all the chemicals
contained within the package. To create a histogram using ggplot2 of the number of days to
steady state, we must first set up a for loop with get_cheminfo and calc_css to generate a
vector containing the data. Vectors containing the average and maximum concentrations at
steady state are also generated in this example, avg and max. The data contained in the days
vector are then plotted as a histogram (Figure 3). We can just as easily create a histogram
containing the average or maximum steady state concentrations by substituting avg or max
for days.



















Figure 3: Days to steady state histogram.
R> library("ggplot2")
R> days <- NULL; avg <- NULL; max <- NULL
R> for (this.cas in get_cheminfo(model="pbtk")) {
+ css.info <- calc_css(chem.cas = this.cas, doses.per.day = 1,
+ suppress.messages = TRUE)
+ days[[this.cas]] <- css.info[["the.day"]]
+ avg[[this.cas]] <- css.info[["avg"]]
+ max[[this.cas]] <- css.info[["max"]]
+ }
R> days.data <- as.data.frame(days)
R> hist <- ggplot(days.data, aes(days)) +
+ geom_histogram(fill = "blue", binwidth = 1/4) + scale_x_log10() +
+ ylab("Number of Chemicals") + xlab("Days") + theme(axis.text =
+ element_text(size = 16), axis.title = element_text(size = 16))
R> hist
Average vs. maximum concentration
We can compare the average and maximum concentrations at steady state using the average
and maximum concentration at steady state vectors, avg and max, from the previous example.
The vectors are bound into a data frame and plotted with a line through the origin with a
slope of 1 (Figure 4).
R> library("ggplot2")
R> avg.max.data <- data.frame(avg, max)
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Figure 4: Average vs. maximum concentration at steady state for 1 dose per day, 1 mg/kg
BW/day.
R> avg.vs.max <- ggplot(avg.max.data, aes(avg, max)) + geom_point() +
+ geom_abline() + scale_x_log10() + scale_y_log10() +
+ xlab("Average Concentration at Steady State (uM)") +
+ ylab("Max Concentration at Steady State (uM)") +
+ theme(axis.text = element_text(size = 16),
+ axis.title = element_text(size = 16))
R> avg.vs.max
3.4. Calculating AUC, peak, and mean values
The function calc_stats calculates the area under the curve (AUC), peak, and mean concen-
trations of any of the solve functions. If a chemical name or CAS number is specified, it will
calculate the specified statistics for that chemical, and if not, it will calculate the values for
all chemicals with sufficient data. To calculate the peak statistics for all chemicals simulated
for 10 days at 1 mg/kg BW/day with 3 doses per day and a list containing the AUC, peak,
and mean for a single 1 mg dose of triclosan over 10 days, we have:
R> all.peak.stats <- calc_stats(days = 10, doses.per.day = 3, stats = "peak")
R> triclosan.stats <- calc_stats(days = 10, chem.name = "triclosan")
3.5. Monte Carlo sampler
The functions calc_mc_css and get_wetmore_css generate Css vectors of Monte Carlo
samples and their quantiles. While calc_mc_css generates new values using the sampler,
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get_wetmore_css retrieves literature values from Wetmore.data. Below are examples of these
two functions, comparing the medians of the Wetmore data in humans for 1 mg/kg BW/day
of Bisphenol A with the calc_mc_css simulation with probability distributions containing a
third of the standard deviation, half the limit of detection for fub, and double the number of
samples of the parameters used in Wetmore et al. (2012) and Wetmore (2015). These exam-
ples do not make use of HTTK-Pop, but vignettes describing the use of HTTK-Pop Monte
Carlo sampler for human variability (Ring et al. 2017) are included in the package.
R> get_wetmore_css(chem.cas = "80-05-7", daily.dose = 1,
+ which.quantile = 0.5, output.units = "uM")
R> calc_mc_css(chem.cas = "80-05-7", daily.dose = 1, which.quantile = 0.5,
+ censored.params = list(Funbound.plasma = list(cv = 0.1, lod = 0.005)),
+ vary.params = list(BW = 0.15, Vliverc = 0.15, Qgfrc = 0.15,
+ Qtotal.liverc = 0.15, million.cells.per.gliver = 0.15, Clint = 0.15),
+ output.units = "uM", samples = 2000, httkpop = FALSE)
The oral equivalent functions convert Css into a dose. Below is an example of a 50 µM
Css of Bisphenol A converted to an oral equivalent dose using the Wetmore data for the
95th quantile of human Css. We can call calc_mc_oral_equiv in the same manner, passing
additional arguments to calc_mc_css within the function and specifying any quantile we
want.
R> get_wetmore_oral_equiv(50, chem.cas = "80-05-7")
We can also use the original Monte Carlo sampler used in calc_mc_css, monte_carlo, to
perform the same simulations using another model. Setting the return.samples argument
of the calc_mc or monte_carlo functions to TRUE, we can generate the sampling distribution
for the Monte Carlo simulation from which the quantiles are calculated. To perform a Monte
Carlo simulation on zoxamide (Figure 5) with the model pbtk with the same limit of detection
and coefficients of variation of two thirds the size of those used in calc_mc_css, we have:
R> vary.params <- NULL
R> params <- parameterize_pbtk(chem.name = "Zoxamide")
R> for (this.param in names(subset(params,
+ names(params) != "Funbound.plasma"))) vary.params[this.param] <- 0.2
R> censored.params <- list(Funbound.plasma = list(cv = 0.2, lod = 0.01))
R> set.seed(1)
R> out <- monte_carlo(params, cv.params = vary.params,
+ censored.params = censored.params, return.samples = TRUE,
+ model = "pbtk", suppress.messages = TRUE)
R> zoxamide <- ggplot(as.data.frame(out), aes(out)) +
+ geom_histogram(fill = "blue", binwidth = 1/6) + scale_x_log10() +
+ ylab("Number of Samples") + xlab("Steady State Concentration (uM)") +
+ theme(axis.text = element_text(size = 16),
+ axis.title = element_text(size = 16))
R> zoxamide

















Figure 5: Sampling distribution of zoxomide Css from the model pbtk.
The out vector is then plotted in a similar way to the days vector in the previous histogram
example. This can also be performed with the new sampler in calc_mc_css by simply setting
model to "pbtk".
3.6. Adding a tissue
The fractional volumes and pH values from Schmitt (2008a) needed to calculate the partition
coefficients are contained in tissue.data. New tissues can be added to this table to generate
their partition coefficients. We can add thyroid to the tissue data by making a row containing
its data, subtracting the volumes and flows from the rest-of-body, and binding the row to
tissue.data. Here we assume it contains the same partition coefficient data as the spleen
and a tenth of the volume and blood flow:
R> new.tissue <- subset(tissue.data,Tissue == "spleen")
R> new.tissue[, "Tissue"] <- "thyroid"
R> new.tissue[new.tissue$variable %in% c("Vol (L/kg)",
+ "Flow (mL/min/kg^(3/4))"),"value"] <- new.tissue[new.tissue$variable
+ %in% c("Vol (L/kg)","Flow (mL/min/kg^(3/4))"),"value"] / 10
R> tissue.data[tissue.data$Tissue == "rest", "value"] <-
+ tissue.data[tissue.data$Tissue == "rest", "value"] -
+ new.tissue[new.tissue$variable %in% c("Vol (L/kg)",
+ "Flow (mL/min/kg^(3/4))"),"value"]
R> tissue.data <- rbind(tissue.data, new.tissue)
We can also choose what tissues we want lumped together or in the rest-of-body compartment.
The tissuelist argument in parameterize_pbtk contains a list of the desired compartment
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names, each containing a vector of the names of the tissues in tissue.data to be lumped
together in that compartment. All unspecified tissues in tissue.data are lumped together
in the rest-of-body. Lumped flows and volumes are calculated through addition of the indi-
vidual component flows and volumes while the lumped partition coefficients are calculated
through dividing the sum of the products of the partition coefficients and their corresponding
compartment volumes by the new lumped volume. To generate the parameters for a model
with kidneys, thyroid, a liver compartment combining the liver and gut, and a rest-of-body
compartment:
R> compartments <- list(liver = c("liver", "gut"), kidney = "kidney",
+ thyroid = "thyroid")
R> parameterize_pbtk(chem.name = "Nicotine", tissuelist = compartments)
No matter which compartments we specify, the liver volume as well as the gut, liver, and
kidney flows are returned for the calculation of clearance and metabolism.
3.7. Export functions
Jarnac (Sauro and Fell 2000) and SBML (Hucka et al. 2003) are commonly used languages for
systems biology models of cellular and physiological processes. In the event that a modeler
wishes to couple such a model to a toxicokinetic model, we provide functions to export
model equations and chemical-specific parameters to these languages. The two functions,
export_pbtk_sbml and export_pbtk_jarnac, have the same arguments and only differ in
the file extension names (.xml and .jan) entered into the filename argument. Both use liters
as the units for volume, but the amounts are unitless and to be determined by the user. If
we suppose that we enter an initial amount of 1 mg in the gut lumen, then all the other
compartments will contain amounts in mg. Below is a call of an export function for a dose
of 1 given to a rat.
R> export_pbtk_sbml(chem.name = "Bisphenol A", species = "Rat",
+ initial.amounts = list(Agutlumen = 1), filename = "PBTKmodel.xml")
4. Concluding remarks
The R software platform is increasingly being used for the statistical analysis of mathemat-
ical models (Wambaugh et al. 2015; Gelman et al. 2013). With the launch of the package
odesolve (Setzer 2001), which was expanded and replaced by deSolve (Soetaert et al. 2010),
R can be used to solve models consisting of systems of differential equations. R further al-
lows organization and handling of large data sets, making it especially suitable for analyzing
the results from high-throughput experiments (Judson et al. 2010). Given the reliance on
mathematical models and in vitro testing to prioritize investigation of the large number of
relatively untested environmental chemicals (Wetmore et al. 2012; Wetmore 2015), software
platforms such as R allow the systematic statistical evaluation of the performance of these
technologies (Wambaugh et al. 2015). httk allows the simulation of four toxicokinetic models
for 553 chemicals (including 415 ToxCast chemicals and 94 pharmaceuticals) in humans, rats,
mice, dogs, and rabbits.
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All models in httk are parameterized using data on key determinants of toxicokinetics that
can be measured in vitro using relatively high-throughput methods (Wetmore et al. 2012;
Wetmore 2015). The package includes toxicokinetic models ranging from a one compartment
model to a PBTK model, but even the PBTK model is relatively spare, with most tissues
lumped into a rest-of-body compartment. Rowland (2004) argued that the “best” model is
the one that most reliably answers the question at hand (Rowland et al. 2004). Thus, the
most parsimonious model – that is, the simplest, most easily understood model allowing useful
predictions – should be preferred (Chiu and White 2006). However, since PBTK models allow
the incorporation of additional, physiological information, we may expect our model pbtk to
be the most accurate on average. We hope these models provide predictions of chemical-
specific toxicokinetics as informed by in vitro data and physicochemical properties without
introducing errors from unnecessary assumptions (Rowland et al. 2004; Chiu and White 2006).
The parameterize_pbtk function provides parameter estimates for more complex models as
needed (Yang and Lu 2007), though our solvers are currently limited to the four model
structures. In future versions, we expect to have the ability to add new compartments using
these parameters and simulate dermal and inhalation exposure.
The httk package provides functions for the application of Monte Carlo methods, in vitro-in
vivo extrapolation, and reverse dosimetry. httk links exposure scenarios, including constant
oral infusion, a single dose, or multiple discrete doses, to predicted tissue and plasma concen-
trations. Standard toxicokinetic statistics including peak concentration and time-integrated
plasma concentration (area under the curve or AUC) can be predicted, facilitating dosimetric
anchoring (Wambaugh et al. 2013a) for comparing in vivo toxicity studies where toxicokinetic
data were not collected (Wetmore et al. 2013). Important aspects of the steady-state behav-
ior of the chemicals can be predicted for use in analysis of biomonitoring data, including the
time to steady-state and Css (Wetmore et al. 2012; Wetmore 2015; Aylward and Hays 2011;
Wambaugh et al. 2013b, 2014). Finally, as ongoing in vitro experiments allow parameteri-
zation of the models for additional chemicals, these new data can be easily distributed as
updates to the package on the CRAN repository.
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